Clinical Trials Arena on MSN39m
Persica’s antibiotic-based drug alleviates lower back pain in Phase Ib trialEvidence has shown that 25% of patients with chronic lower back pain could be suffering from an infection in the disc space.
Vertex Pharmaceuticals’ (VRTX) non-opioid pain drug Journavx was picked up by UnitedHealth’s (UNH) Optum on “Tier 3.” The insurer said, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback